Scientists on Monday hailed a breakthrough for severe asthma treatment as a study found that the condition can be controlled by a regular injection of an antibody, eliminating the need for an inhaler.

The FDA has approved AstraZeneca’s asthma injection, benralizumab ... Fasenra is now approved in the US for the add-on maintenance treatment of patients with severe asthma aged 12 years and ...

Our goal is to provide the best combination of effectiveness and safety for each patient undergoing allergy shot treatments ... for any active asthma symptoms before administering your shot. You will ...

The FDA is to review Sanofi/Regeneron's Dupixent as a treatment for asthma, a new use that could ... but can be considered a rival because it is also an injection. Patients may opt to take the ...

Its efficacy and safety have been established in the treatment of asthma, allergic rhinitis/rhinoconjunctivitis and stinging insect hypersensitivity in numerous controlled clinical trials.

Drugs already taken by millions of diabetes patients appear to also help slash asthma attacks by up to 70%, new British research shows.

Scientists from the University of Sharjah think monoclonal antibodies hold the potential to be a far better treatment for asthma exacerbations than conventional therapies like steroids. They also ...

Itchy eyes, rashes, sneezing, wheezing, swelling and shortness of breath are among the symptoms shared by about 50 million ...

Six months after Amgen and AstraZeneca reported promising results for Tezspire (t | A phase 3 study has shown that ...

An asthma attack is much more than just feeling winded after exercise and needing to catch your breath. Learn what can trigger an attack and what to do if you... Allergies can affect everyone ...

The government has increased the cost of certain essential drugs for treating asthma, tuberculosis and others.